GlassScriptPhysician profile
Sampath Gunda
NPI 1477865301
$72,915.53
in general payments reported to CMS, 2019-2025
18 companies · $442 in 2025
The $442 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $45K · 2021: $348 · 2022: $1,272 · 2023: $3,264 · 2024: $2,536 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,499 · Food and Beverage: $2,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,498.97 |
| Food and Beverage | $2,742.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $41,667.67 | 2019-2020 | |
| Boston Scientific Corporation | $19,652.70 | 2019-2024 | Watchman Access System, Watchman Flx |
| Abbott Laboratories | $5,116.86 | 2019-2024 | Agilis, Aveir, Jot Dx |
| Biotronik INC. | $3,222.64 | 2019-2023 | |
| Medtronic, INC. | $1,962.97 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Azure Xt Dr Mri Surescan |
| Biosense Webster, INC. | $383.04 | 2021-2025 | Carto 3 |
| Janssen Pharmaceuticals, INC | $155.06 | 2023-2024 | Xarelto |
| Atricure, INC. | $146.97 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $95.28 | 2022-2023 | Camzyos |
| Acutus Medical, INC. | $87.15 | 2023 | |
| Pfizer INC. | $84.27 | 2022-2023 | |
| Philips North America LLC | $74.45 | 2023 | |
| Novartis Pharmaceuticals Corporation | $70.52 | 2021-2024 | |
| Cardiva Medical, INC. | $68.67 | 2021-2022 | |
| Amgen INC. | $39.29 | 2023 | Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $33.63 | 2023 | Uptravi, Opsumit |
| Abiomed | $33.59 | 2021-2023 | Impella |
| Elutia, INC. | $20.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sampath Gunda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.